Our results revealed that STZ injection disrupted pancreatic beta cell function, resulting in elevated levels of FBG and HbA1c, increased blood insulin levels, and insulin resistance, indicating successful establishment of the T2DM model. The gene discussed is INS; the disease is Insulin resistance.